Relatively little is known about oncogene involvement in the regulation of Fas-mediated apoptosis. Inhibition of Fas-induced cell death by the bcl-2 oncogene has been demonstrated to be only partial. In light of a growing body of evidence for the Abl kinase as a negative regulator of cell death, we sought to determine whether Abl expression could protect against Fas-mediated cell death. To address this question, we utilized two separate strategies. In the first, we expressed human Fas in K562, a chronic myelogenous leukemia cell line, which constitutively expresses bcr-abl and examined the effects of Fas ligation in these cells. Fas-positive K562 transformants (K562.Fas) were found to be protected against Fas-mediated cell death. However, down-regulation of Bcr-Abl protein levels in K562.Fas cells using antisense oligonucleotides targeted to bcr-abl mRNA rendered these cells highly susceptible to Fas-induced death. In the second approach we utilized a Fas-positive HL-60 cell line, which we transfected with a temperature-sensitive mutant of v-Abl. HL-60.v-Abl transfectants were found to be protected from Fas-induced apoptosis at the permissive but not the restrictive temperature for the Abl kinase. Taken together, these observations identify the Abl kinase as a negative regulator of Fas-mediated cell death. Since Abl was also found to block apoptosis mediated by ceramide, a recently proposed downstream effector of the apoptotic pathway initiated by Fas, we propose that Abl exerts its protective effects downstream of the early Fas-initiated signaling events.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. C. Briggs, K. E. Shults, L. A. Flye, S. A. McClintock-Treep, M. H. Jagasia, S. A. Goodman, F. I. Boulos, J. W. Jacobberger, G. T. Stelzer, and D. R. Head Dysregulated Human Myeloid Nuclear Differentiation Antigen Expression in Myelodysplastic Syndromes: Evidence for a Role in Apoptosis. Cancer Res., May 1, 2006; 66(9): 4645 - 4651. [Abstract] [Full Text] [PDF]

				D. Barila, A. Rufini, I. Condo, N. Ventura, K. Dorey, G. Superti-Furga, and R. Testi Caspase-Dependent Cleavage of c-Abl Contributes to Apoptosis Mol. Cell. Biol., April 15, 2003; 23(8): 2790 - 2799. [Abstract] [Full Text] [PDF]

				C. Pipaon, P. Gutierrez, J. C. Montero, M. Lorenzo, A. Eguiraun, J. A. De la Fuente, A. Pandiella, J. Leon, and J. M. Ortiz Mitogen-activated Protein Kinase Routes as Targets in the Action of Diaza-anthracene Compounds with a Potent Growth-inhibitory Effect on Cancer Cells Mol. Cancer Ther., August 1, 2002; 1(10): 811 - 819. [Abstract] [Full Text] [PDF]

				S. Gil-Parrado, A. Fernandez-Montalvan, I. Assfalg-Machleidt, O. Popp, F. Bestvater, A. Holloschi, T. A. Knoch, E. A. Auerswald, K. Welsh, J. C. Reed, et al. Ionomycin-activated Calpain Triggers Apoptosis. A PROBABLE ROLE FOR Bcl-2 FAMILY MEMBERS J. Biol. Chem., July 19, 2002; 277(30): 27217 - 27226. [Abstract] [Full Text] [PDF]

				J. Sonoyama, I. Matsumura, S. Ezoe, Y. Satoh, X. Zhang, Y. Kataoka, E. Takai, M. Mizuki, T. Machii, H. Wakao, et al. Functional Cooperation among Ras, STAT5, and Phosphatidylinositol 3-Kinase Is Required for Full Oncogenic Activities of BCR/ABL in K562 Cells J. Biol. Chem., March 1, 2002; 277(10): 8076 - 8082. [Abstract] [Full Text] [PDF]

				E. Laurent, M. Talpaz, H. Kantarjian, and R. Kurzrock The BCR Gene and Philadelphia Chromosome-positive Leukemogenesis Cancer Res., March 1, 2001; 61(6): 2343 - 2355. [Full Text]

				M. M. Mc Gee, G. Campiani, A. Ramunno, C. Fattorusso, V. Nacci, M. Lawler, D. C. Williams, and D. M. Zisterer Pyrrolo-1,5-benzoxazepines Induce Apoptosis in Chronic Myelogenous Leukemia (CML) Cells by Bypassing the Apoptotic Suppressor Bcr-Abl J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 31 - 40. [Abstract] [Full Text]

				R.-Y. Bai, T. Ouyang, C. Miething, S. W. Morris, C. Peschel, and J. Duyster Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway Blood, December 15, 2000; 96(13): 4319 - 4327. [Abstract] [Full Text] [PDF]

				M. W. N. Deininger, J. M. Goldman, and J. V. Melo The molecular biology of chronic myeloid leukemia Blood, November 15, 2000; 96(10): 3343 - 3356. [Full Text] [PDF]

				T. Stiewe, K. Parssanedjad, H. Esche, B. Opalka, and B. M. Pützer E1A Overcomes the Apoptosis Block in BCR-ABL+ Leukemia Cells and Renders Cells Susceptible to Induction of Apoptosis by Chemotherapeutic Agents Cancer Res., July 1, 2000; 60(14): 3957 - 3964. [Abstract] [Full Text]

				T. Kondo, T. Matsuda, M. Tashima, H. Umehara, N. Domae, K. Yokoyama, T. Uchiyama, and T. Okazaki Suppression of Heat Shock Protein-70 by Ceramide in Heat Shock-induced HL-60 Cell Apoptosis J. Biol. Chem., March 17, 2000; 275(12): 8872 - 8879. [Abstract] [Full Text] [PDF]

				M. S. Neshat, A. B. Raitano, H.-G. Wang, J. C. Reed, and C. L. Sawyers The Survival Function of the Bcr-Abl Oncogene Is Mediated by Bad-Dependent and -Independent Pathways: Roles for Phosphatidylinositol 3-Kinase and Raf Mol. Cell. Biol., February 15, 2000; 20(4): 1179 - 1186. [Abstract] [Full Text]

				I. Unnikrishnan, A. Radfar, J. Jenab-Wolcott, and N. Rosenberg p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells Mol. Cell. Biol., July 1, 1999; 19(7): 4825 - 4831. [Abstract] [Full Text] [PDF]

				C. Selleri, J. P. Maciejewski, F. Pane, L. Luciano, A. M. Raiola, I. Mostarda, F. Salvatore, and B. Rotoli Fas-Mediated Modulation of Bcr/Abl in Chronic Myelogenous Leukemia Results in Differential Effects on Apoptosis Blood, August 1, 1998; 92(3): 981 - 989. [Abstract] [Full Text] [PDF]

				L. Dubrez, B. Eymin, O. Sordet, N. Droin, A. G. Turhan, and E. Solary BCR-ABL Delays Apoptosis Upstream of Procaspase-3 Activation Blood, April 1, 1998; 91(7): 2415 - 2422. [Abstract] [Full Text] [PDF]

				T. H. Holmstrom, S. C. Chow, I. Elo, E. T. Coffey, S. Orrenius, L. Sistonen, and J. E. Eriksson Suppression of Fas/APO-1-Mediated Apoptosis by Mitogen-Activated Kinase Signaling J. Immunol., March 15, 1998; 160(6): 2626 - 2636. [Abstract] [Full Text] [PDF]

				G. P. Amarante-Mendes, C. Naekyung Kim, L. Liu, Y. Huang, C. L. Perkins, D. R. Green, and K. Bhalla Bcr-Abl Exerts Its Antiapoptotic Effect Against Diverse Apoptotic Stimuli Through Blockage of Mitochondrial Release of Cytochrome C and Activation of Caspase-3 Blood, March 1, 1998; 91(5): 1700 - 1705. [Abstract] [Full Text] [PDF]

				H. Hebestreit, B. Dibbert, I. Balatti, D. Braun, A. Schapowal, K. Blaser, and H.-U. Simon Disruption of Fas Receptor Signaling by Nitric Oxide in Eosinophils J. Exp. Med., February 2, 1998; 187(3): 415 - 425. [Abstract] [Full Text] [PDF]

				L. M. Martins, P. W. Mesner, T. J. Kottke, G. S. Basi, S. Sinha, J. S. Tung, P. A. Svingen, B. J. Madden, A. Takahashi, D. J. McCormick, et al. Comparison of Caspase Activation and Subcellular Localization in HL-60 and K562 Cells Undergoing Etoposide-Induced Apoptosis Blood, December 1, 1997; 90(11): 4283 - 4296. [Abstract] [Full Text] [PDF]

				E. Cuppen, S. Nagata, B. Wieringa, and W. Hendriks No Evidence for Involvement of Mouse Protein-tyrosine Phosphatase-BAS-like Fas-associated Phosphatase-1 in Fas-mediated Apoptosis J. Biol. Chem., November 28, 1997; 272(48): 30215 - 30220. [Abstract] [Full Text] [PDF]

				J. A. Houghton, F. G. Harwood, and D. M. Tillman Thymineless death in colon carcinoma cells is mediated via Fas signaling PNAS, July 22, 1997; 94(15): 8144 - 8149. [Abstract] [Full Text] [PDF]

				D. McConkey and S Orrenius Signal transduction pathways in apoptosis Stem Cells, November 1, 1996; 14(6): 619 - 631. [Abstract]

				M. Smith, J. Abrams, E. L. Trimble, and R. S. Ungerleider Dose Intensity of Chemotherapy for Childhood Cancers Oncologist, October 1, 1996; 1(5): 293 - 304. [Abstract] [Full Text] [PDF]